BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Net Tangible Assets

Latest net tangible assets for AEZS: $26M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$26.23M
↓ 9.81% YoYΔ $-2.85M vs prior year quarter

Peer average / median

Loading

COSCIENS Biopharma Net Tangible Assets History

Loading

COSCIENS Biopharma vs. peers: Net Tangible Assets Comparison

Loading

COSCIENS Biopharma Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (AEZS) FAQ

As of the most recent data (June 2024), AEZS shows a net tangible assets of $26M. That compares with $29M in the prior-year period — down 9.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AEZS's net tangible assets is now $26M (was $29M) — a 9.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether COSCIENS Biopharma is outperforming or lagging.

Tracking AEZS's net tangible assets over time shows whether COSCIENS Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $29M in the prior-year period — down 9.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has COSCIENS Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $26M) with ownership activity and broader fundamentals.

COSCIENS Biopharma's net tangible assets is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.